This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Prevention

Authoring team

Immunoprophylaxis may be:

  • passive - hepatitis B immunoglobulin
  • active - hepatitis B vaccine

There has been some concern that variants of hepatitis B virus might prevent their control by vaccination, particularly since these variants develop in a large proportion of chronic carriers. Initial indications however suggest that these viral escape mutants do not alter substantially the effectiveness of vaccination programmes aimed at large populations.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.